DIASORIN (Germany) Top Management

34D Stock  EUR 68.44  0.00  0.00%   
DIASORIN employs about 29 people. The company is managed by 20 executives with a total tenure of roughly 241 years, averaging almost 12.0 years of service per executive, having 1.45 employees per reported executive. Evaluation of DIASORIN's management performance can provide insight into the firm performance.
Carlo Rosa  CEO
Chief Executive Officer, Executive Director, General Manager
Michele Denegri  Chairman
Non-Executive Deputy Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DIASORIN. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

DIASORIN Management Team Effectiveness

DIASORIN's management efficiency ratios could be used to measure how well DIASORIN manages its routine affairs as well as how well it operates its assets and liabilities.
Some institutional investors establish a significant position in stocks such as DIASORIN in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DIASORIN, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

DIASORIN Workforce Comparison

DIASORIN is rated third in number of employees category among its peers. The total workforce of Other industry is presently estimated at about 87.0. DIASORIN totals roughly 29.0 in number of employees claiming about 33% of all equities under Other industry.

DIASORIN Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. DIASORIN Price Series Summation is a cross summation of DIASORIN price series and its benchmark/peer.

DIASORIN Notable Stakeholders

A DIASORIN stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DIASORIN often face trade-offs trying to please all of them. DIASORIN's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DIASORIN's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carlo RosaChief Executive Officer, Executive Director, General ManagerProfile
Michele DenegriNon-Executive Deputy Chairman of the BoardProfile
Gustavo DenegriNon-Executive Chairman of the BoardProfile
Stefano RonchiSenior Corporate Vice President - Human ResourcesProfile
Chen EvenSenior Corporate Vice President - Commercial Operations and Executive DirectorProfile
Piergiorgio PedronSenior Corporate VP and Chief Financial OfficerProfile
Francesca PasinelliIndependent DirectorProfile
Giancarlo BoschettiNon-Executive DirectorProfile
Tullia TodrosIndependent DirectorProfile
Riccardo FavaExternal Relations Director, Head of Investor Relations and MediaProfile
Giuseppe AlessandriaLead Independent DirectorProfile
Roberta SomatiIndependent DirectorProfile
Stefano AltaraNon-Executive DirectorProfile
Franco MoscettiIndependent DirectorProfile
Fiorella AltrudaIndependent DirectorProfile
Monica TardivoIndependent DirectorProfile
Elisa CorghiIndependent DirectorProfile
John GeracePresident DiaSorin Molecular LLCProfile
Luca MelindoNon-Executive DirectorProfile
Ugo GaySenior Corporate Vice President - Industrial OperationsProfile
String symbol = request.getParameter("s");

About DIASORIN Management Performance

The success or failure of an entity such as DIASORIN often depends on how effective the management is. DIASORIN management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DIASORIN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DIASORIN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of DIASORIN's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DIASORIN's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DIASORIN's management manipulating its earnings.

DIASORIN Workforce Analysis

Traditionally, organizations such as DIASORIN use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DIASORIN within its industry.

DIASORIN Manpower Efficiency

Return on DIASORIN Manpower

Revenue Per Employee42.7M
Revenue Per Executive61.9M
Net Income Per Employee10.7M
Net Income Per Executive15.5M

Complementary Tools for DIASORIN Stock analysis

When running DIASORIN's price analysis, check to measure DIASORIN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIASORIN is operating at the current time. Most of DIASORIN's value examination focuses on studying past and present price action to predict the probability of DIASORIN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIASORIN's price. Additionally, you may evaluate how the addition of DIASORIN to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk